Skip to main content
. 2024 May 3;14:10162. doi: 10.1038/s41598-024-60833-w

Table 1.

Patients’ demographics.

Chemotherapy group
Participants (n) 708
Age (years)# 70.4 ± 6.9
Sex (male/female) 645/63
Smoking history (presence/absence/unknown) 684/20/4
Smoking index (pack-years)# N = 677, 55.3 ± 30
Emphysema (presence/absence/unknown) 326/381/1
Performance status
 0/1/2/3/4 226/378/84/16/4
Interstitial pneumonia
Clinical diagnosis of IIP (IPF/non-IPF/unknown) 406/294/8
HRCT pattern
 UIP pattern 275
 Possible UIP pattern 243
 Inconsistent with the UIP pattern 190
History of acute exacerbation (presence/absence/unknown) 11/689/8
Desaturation on exertion (presence/absence/unknown) 80/418/210
%FVC (%)# n = 441, 88.6 ± 19.14
%DLco (%)# n = 238, 64 ± 22.56
KL-6 (U/mL)# n = 564, 922.8 ± 985.25
SP-D (ng/mL)# n = 406, 135.6 ± 102.9
Treatment
 None 678
 Prednisolone 15
 Prednisolone + immunosuppressants 5
 Pirfenidone 7
 NAC 1
 Pirfenidone + NAC 1
 Pirfenidone + prednisolone 1
Lung cancer
Histopathologic type
 Small cell carcinoma 216
 Non-small cell carcinoma 492
  Adenocarcinoma 258
  Squamous cell carcinoma 173
  LCNEC 17
  LCC 9
  Others 35
EGFR mutation status
 Negative 274
 Positive 13
  L858R/deletion 21 9/4
 Not evaluated 421
ALK re-arrangement
 Negative 124
 Positive 2
 Not evaluated 582

ALK anaplastic lymphoma kinase, BSC best supportive care, EGFR epidermal growth factor receptor, %DLco percentage of predicted diffusing capacity of the lung for monoxide, %FVC percentage of predicted forced vital capacity, HRCT high-resolution computed tomography, IIP idiopathic interstitial pneumonia, IPF idiopathic pulmonary fibrosis, KL-6 Krebs von den Lungen-6, LCC large cell carcinoma, LCNEC large cell neuroendocrine carcinoma, NAC inhaled N-acetylcysteine, PS eastern cooperative oncology group performance status, SP-D surfactant protein-D, UIP usual interstitial pneumonia.

#Mean ± standard deviation.